These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Intravesical drug therapy in women with severe urge incontinence. Clinical experiences from a department of gynecology]. Johansen JK; Lose G Ugeskr Laeger; 1999 Nov; 161(44):6052-5. PubMed ID: 10778341 [TBL] [Abstract][Full Text] [Related]
9. [Therapeutic effects of intrarectal administration of oxybutynin]. Radziszewski P; Borkowski A Wiad Lek; 2002; 55(11-12):691-8. PubMed ID: 12715351 [TBL] [Abstract][Full Text] [Related]
10. Intravesical oxybutynin for treating incontinence resulting from an overactive detrusor. Lose G; Nørgaard JP BJU Int; 2001 Jun; 87(9):767-73. PubMed ID: 11412211 [No Abstract] [Full Text] [Related]
11. [Intravesical oxybutynin in children with meningomyelocele. Efficient treatment with few side-effects]. Von Zweigbergk M; Nordin B; Jonsson S Lakartidningen; 1996 Oct; 93(41):3573-6. PubMed ID: 8965514 [No Abstract] [Full Text] [Related]
15. Severe Xerostomia Secondary to Anticholinergic Drug Therapy: Case Report. Brown RS; Rhodes BH; Siewe MS; Matthews TJ Dent Today; 2017 Feb; 36(2):136-8. PubMed ID: 29235767 [No Abstract] [Full Text] [Related]
16. Transdermal oxybutynin: sticking to the facts. Cartwright R; Cardozo L Eur Urol; 2007 Apr; 51(4):907-14; discussion 914. PubMed ID: 17157979 [TBL] [Abstract][Full Text] [Related]
17. Low-dose oxybutynin for the treatment of urge incontinence: good efficacy and few side effects. Bemelmans BL; Kiemeney LA; Debruyne FM Eur Urol; 2000 Jun; 37(6):709-13. PubMed ID: 10828672 [TBL] [Abstract][Full Text] [Related]
18. Transdermal oxybutynin. A viewpoint by Michael Chancellor. Chancellor M Drugs Aging; 2003; 20(11):865-6. PubMed ID: 12964893 [No Abstract] [Full Text] [Related]
19. Transdermal oxybutynin. A viewpoint by Adrian Wagg. Wagg A Drugs Aging; 2003; 20(11):865-6. PubMed ID: 12964894 [No Abstract] [Full Text] [Related]